Search results
-
Mr Oscar Baldwin
... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...
-
Dr Saif Ahmad
I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...
-
Dr Sujath Abbas
... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...
-
Professor Walid Khaled
... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...
-
Dr David Gilligan
David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...
-
Mr David Thurtle
Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer
-
Dr Roisin Owens
Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...
-
Mr Thierry Lefebvre
Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...
-
Mr Adam Palmer
-
Dr Avgi Andreou
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Miss Alicia Garcia Gimenez
-
Mr Adrian Lascu
-
Miss Aleksandra Kruglikov
-
Dr Andrew Reynolds
-
Mr Angelos Kolias
Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...
-
Dr Antony Rix
Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...
-
Professor Tony Green
Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Dr Danish Mazhar
Dr Mazhar was a Medical Undergraduate at the University of Oxford and completed his Clinical Training in London. He undertook Specialist Training in Medical Oncology at the Hammersmith and Charing Cross Hospitals in London. He was awarded a PhD by...
-
Mr Giuseppe Aresu
Mr Aresu is a Consultant Thoracic Surgeon at the Royal Papworth Hospital. He undertook his Cardiothoracic specialist training in Padua, Udine (Italy) and in Bristol (UK). In November 2011 he started working as consultant thoracic surgeon in Udine where...
-
Dr James Nathan
Cellular mechanisms of oxygen and metabolite sensing: ...
-
Mrs Jane Bushen
-
Mrs Jane Lichfield
-
Dr Jane Dobson
As a Veterinary Oncologist, I am interested in many aspects of cancer including diagnostic methods and treatment of commonly occuring cancers in animals eg lymphoma and osteosarcoma. Animals cancer patients could provide an excellent model for...
-
Dr Janet Maguire
-
Dr Jan Czarnecki
-
Dr Ljiljana Fruk
-
Mr James Watson
-
Mrs Sarah Fesco
-
Dr David Fairen-Jimenez
Our research concerns the study of the molecular mechanisms that control adsorption processes in porous materials. We are particularly interested in drug delivery systems, where nanotechnology has a fundamental impact to revolutionise cancer diagnosis...
-
Miss Jamie McGinn
Project title: Epithelial cell dynamics during postnatal growth; relevance for ...
-
Dr Ali Amin Al Olama
... at highest risk of developing prostate cancer could be useful for prevention and screening programs. ...
-
Mr Arqum Anwar
... the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass spectrometry. The ...
-
Dr Andreas Bender
Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...
-
Professor Adrian Liston
We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...
-
Dr Ashray Gunjur
I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...
-
Dr Adrien Hallou
Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...
-
Dr Ahsan MEMON
Ahsan has developed a sui generis versatile holographic system capable of diverse photo-perturbation techniques including photo-manipulation, photo-activation, photo-ablation, optical-trapping and optogenetics, combined with multi-modal imaging...
-
Professor Sir Bruce Ponder
... enriched for genes associated with the 72 GWAS loci formally confirmed at the time of our analysis. These regulons and their TFs show ...
